MedTrace Logo

IV Iron in Association With Tranexamic Acid for Hip Fracture

NCT02428868 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-04-29

No results posted yet for this study

Summary

It is a prospective randomized controlled study aiming to test if tranexamic acid combined to intravenous iron before and after surgery for hip fracture in elderly can decrease peri-operative red cell transfusion.

Conditions

Interventions

DRUG

tranexamic acid (Exacyl®)

1 gram diluted in 20 mL saline solution, in 30 minutes, five minutes before skin incision and a second 1 gram, 3 hours later

DRUG

intravenous iron (Ferroven®)

2 vials of 10 mL containing each one 100 mg iron, diluted in 100 mL normal saline over 30 minutes before induction of anesthesia and repeated on day two and three.

OTHER

Saline

20 mL saline in 30 minutes, five minutes before skin incision and 20 ml 3 hours later.

Sponsors & Collaborators

  • Institut Kassab d'Orthopédie

    lead OTHER

Principal Investigators

  • Olfa Kaabachi, Professor · Institut Mohamed Kassab d'Orthopédie

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428868 on ClinicalTrials.gov